In a 65-year-old man with cirrhosis due to chronic hepatitis C presenting with worsening ascites, oliguria, hypotension, hyponatremia, rapidly rising serum creatinine, very low urinary sodium, ascitic fluid not meeting spontaneous bacterial peritonitis criteria, and a normal renal ultrasound while on furosemide and spironolactone, what is the most likely diagnosis: acute interstitial nephritis, acute glomerulonephritis, acute tubular necrosis, or hepatorenal syndrome?

Hepatorenal Syndrome (D)

The most likely diagnosis is hepatorenal syndrome (HRS). This patient presents with the classic constellation of findings that define HRS-AKI in the setting of advanced cirrhosis: rapidly rising serum creatinine (from 1.3 to 2.8 mg/dL over 2 weeks), oliguria, hypotension, very low urinary sodium (<10 mEq/L indicating avid sodium retention), hyponatremia, and a normal renal ultrasound—all occurring in a patient with cirrhosis and ascites 1, 2.

Why This is Hepatorenal Syndrome

The diagnostic criteria for HRS are met in this case 3, 1:

• Cirrhosis with ascites (present)
• Serum creatinine ≥1.5 mg/dL (2.8 mg/dL, representing a doubling from baseline)
• No improvement after diuretic withdrawal and volume expansion (implied by worsening despite being on diuretics)
• Absence of shock (BP 90/60 is low but not frank shock)
• No nephrotoxic drugs (furosemide and spironolactone are standard therapy)
• Normal renal imaging (excludes structural kidney disease)
• Urine sodium <10 mEq/L (pathognomonic for functional renal vasoconstriction)

The very low urinary sodium is particularly telling—it reflects the intense renal vasoconstriction and sodium avidity that characterizes HRS, driven by splanchnic vasodilation and activation of the renin-angiotensin-aldosterone system 1, 2, 4.

Why Not the Other Options

Acute tubular necrosis (ATN) would typically show:

• Urinary sodium >40 mEq/L (not <10 mEq/L)
• Muddy brown casts on urinalysis
• History of a clear ischemic or nephrotoxic insult
• Less dramatic response to vasoconstrictors

Acute interstitial nephritis (AIN) would show:

• Urinary eosinophils or white blood cell casts
• Recent medication exposure (though diuretics can rarely cause AIN)
• Typically urinary sodium >40 mEq/L
• Often fever, rash, or other systemic symptoms

Acute glomerulonephritis would demonstrate:

• Hematuria with red blood cell casts
• Significant proteinuria (>500 mg/day)
• Active urinary sediment
• The patient has none of these findings

Critical Pathophysiology

HRS develops from progressive circulatory dysfunction in cirrhosis 5, 4:

1. Splanchnic vasodilation from portal hypertension creates effective arterial underfilling
2. Compensatory mechanisms activate: renin-angiotensin-aldosterone system, sympathetic nervous system, vasopressin
3. Renal vasoconstriction results, causing marked reduction in GFR
4. Sodium and water retention worsens, leading to hyponatremia and oliguria
5. Triggering events (infection, diuretic overuse, hypotension) precipitate acute decompensation

The ascitic fluid analysis showing WBC 165/μL with only 25% PMNs (approximately 41 cells/μL) rules out spontaneous bacterial peritonitis (which requires ≥250 PMN/μL), but infection remains a common trigger for HRS even without frank SBP 1, 4.

Clinical Implications and Management

This diagnosis carries grave prognostic significance 4, 6:

• Median survival without treatment: ≤3 months
• Mortality risk substantially elevated
• Urgent need for definitive therapy

Immediate management priorities 1, 2:

1. Discontinue diuretics immediately (furosemide and spironolactone are worsening effective arterial volume) 7
2. Volume expansion with albumin (1 g/kg/day up to 100 g/day for 2 days) 3, 1
3. Initiate vasoconstrictor therapy if creatinine remains elevated after volume expansion:
   • Terlipressin + albumin (40-60% response rate) 8
   • Alternative: midodrine + octreotide + albumin if terlipressin unavailable 1
4. Evaluate for liver transplantation urgently (definitive treatment) 2
5. Rule out and treat precipitating factors: infection, GI bleeding, nephrotoxins 1

Common Pitfalls to Avoid

• Do not continue diuretics in suspected HRS—they worsen effective arterial volume and precipitate further renal dysfunction 7
• Do not delay vasoconstrictor therapy waiting for "more data"—early initiation improves outcomes 1, 4
• Do not assume ATN just because creatinine is rising—the urinary sodium <10 mEq/L is diagnostic for functional (HRS) rather than structural (ATN) kidney injury
• Do not overlook occult infection—even without SBP, bacterial translocation and systemic inflammation drive HRS pathogenesis 9, 4

The hypotension (90/60 mmHg) in this patient is particularly concerning as it reflects severe circulatory dysfunction and may require holding beta-blockers if prescribed for portal hypertension 5. The hyponatremia (130 mEq/L) indicates advanced disease with impaired free water excretion and should prompt fluid restriction to 1-1.5 L/day once HRS treatment is initiated 5.